Lenalidomide improves the therapeutic effect of an interferon- α-dendritic cell-based lymphoma vaccine

In conclusion, our data demonstrate that IFN-DC-based vaccination plus lenalidomide exert an additive therapeutic effect in xenochimeric mice bearing established lymphoma. These results may pave the way to evaluate this co mbination in the clinical ground.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research